APP and Alzheimer disease: Recently, Olah et al. [148] reported a novel mechanism underlying PV+ interneuron hypoexcitability in a mouse model of familial AD that rapidly develops severe amyloid pathology (i.e. the 5xFAD mouse, which expresses human APP and PSEN1 transgenes with a total of five AD-linked mutations).